TScan Therapeutics, Inc. TCRX
0.19 USD +0.01 (+5.97%)
Nov 3, 2026, 3:12 PM EST
0.1768 Day range 0.1919
0.173 52-week range 1.47
- YTD
- -81.02%
- 1 year
- -84.69%
Held by funds
5 US ETFs and mutual funds hold TCRX · largest positions
Ownership
Held by insiders 0.82%
Held by institutions 86.11%
Float held by institutions 86.82%
Institutions 124
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Lynx1 Capital Management Lp | 10.64% | 5,224,600 | 15.73M | Sep 29, 2024 |
| EcoR1 Capital, LLC | 10.18% | 5,000,000 | 15.05M | Sep 29, 2024 |
| Blackrock Inc. | 9.44% | 4,632,876 | 13.94M | Sep 29, 2024 |
| Adage Capital Partners GP L.L.C. | 8.96% | 4,400,000 | 13.24M | Sep 29, 2024 |
| BVF Inc. | 6.09% | 2,989,474 | 9.00M | Sep 29, 2024 |
| Baker Bros. Advisors, LP | 5.67% | 2,784,792 | 8.38M | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.79% | 1,370,394 | 4.12M | Sep 29, 2024 |
| Simplify Exchange Traded Fds-Simplify Propel Opportunities ETF | 2.13% | 1,046,916 | 3.15M | Sep 29, 2024 |
| BlackRock Health Sciences Term Trust | 2.13% | 1,045,767 | 3.15M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 1.97% | 967,477 | 2.91M | Oct 30, 2024 |
| Blackrock Funds-Health Sciences Opportunity Portfolio | 1.39% | 681,015 | 2.05M | Aug 30, 2024 |
| Vanguard Extended Market Index Fund | 1.31% | 645,510 | 1.94M | Sep 29, 2024 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BARBERICH TIMOTHY JOSEPH | Director | Purchase | Dec 18, 2023 | 100,286 |
| KLENCKE BARBARA M.D. | Director | Purchase | Sep 22, 2024 | 70,000 |
| LYNX1 CAPITAL MANAGEMENT LP | Beneficial Owner of more than 10% of a Class of Security | Purchase | Dec 12, 2024 | 0 |
| SILVER BRIAN M. | Chief Financial Officer | Purchase | Dec 27, 2022 | 32,885 |
| ZDRAVESKI ZORAN | Officer | Sale | Aug 22, 2024 | 4,716 |